Patents by Inventor Luigi Mosconi

Luigi Mosconi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20090062388
    Abstract: The invention relates to the use of the acetyl L-carnitine, or a pharmaceutically acceptable salt thereof for the preparation of a medication for the preventive therapy for pain.
    Type: Application
    Filed: September 26, 2008
    Publication date: March 5, 2009
    Applicant: Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
    Inventors: Menotti Calvani, Luigi Mosconi
  • Publication number: 20060148896
    Abstract: The present invention relates to the use of an alkanoyl L-carnitine, or pharmaceutically acceptable salt thereof, for the preparation of a medicament for the treatment of anhedonia.
    Type: Application
    Filed: December 20, 2005
    Publication date: July 6, 2006
    Applicant: Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
    Inventors: Menotti Calvani, Luigi Mosconi
  • Publication number: 20040171685
    Abstract: The present invention relates to the use of an alkanoyl L-carnitine, or a pharmaceutically acceptable salt thereof, for the preparation of a medicament for the treatment of anhedonia.
    Type: Application
    Filed: November 26, 2003
    Publication date: September 2, 2004
    Inventors: Menotti Calvani, Luigi Mosconi
  • Publication number: 20040152781
    Abstract: The invention relates to the use of the acetyl L-carnitine, or a pharmaceutically acceptable salt thereof for the preparation of a medication for the preventive therapy for pain.
    Type: Application
    Filed: March 4, 2004
    Publication date: August 5, 2004
    Inventors: Menotti Calvani, Luigi Mosconi
  • Patent number: 6348495
    Abstract: A method for treating celiac disease comprising administration of a composition containing an alkanoyl L-carnitine wherein the alkanoyl group is straight or branched and has 2-6 carbon atoms and the pharmacologically acceptable salts thereof.
    Type: Grant
    Filed: July 26, 2000
    Date of Patent: February 19, 2002
    Assignee: Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
    Inventors: Claudio Cavazza, Luigi Mosconi
  • Patent number: 5958941
    Abstract: The use of L-carnitine or of an alkanoyl L-carnitine or their pharmacologically acceptable salts is described for producing a medicament for inhibiting nephrotoxicity and vasculotoxicity resulting from the administration of an immunosuppressant drug such as cyclosporin-A, tacrolimus, rapamicine and deoxyspergualine.
    Type: Grant
    Filed: September 8, 1997
    Date of Patent: September 28, 1999
    Assignee: Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
    Inventors: Menotti Calvani, Luigi Mosconi
  • Patent number: 5955424
    Abstract: The use of L-carnitine or of an alkanoyl L-carnitine or their pharmacologically acceptable salts is described for producing a medicament for inhibiting nephrotoxicity and vasculotoxicity resulting from the administration of an immunosuppressant drug such as cyclosporin-A, tacrolimus, rapamicine and deoxyspergualine.
    Type: Grant
    Filed: January 3, 1996
    Date of Patent: September 21, 1999
    Assignee: Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
    Inventors: Menotti Calvani, Luigi Mosconi
  • Patent number: 4751242
    Abstract: Oral or parenteral administration of 1,000-2,000 mg/day of acetyl L-carnitine or an equivalent amount of a pharmacologically acceptable salt thereof to patients affected by acute or chronic peripheral neuropathy dramatically improves their symptomatological pattern.
    Type: Grant
    Filed: July 27, 1987
    Date of Patent: June 14, 1988
    Assignee: Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
    Inventors: Menotti Calvani, Luigi Mosconi